Board of Directors

Howard Jonas (CEO and Chairman), >30-year experience as founder and CEO of multi-billion-dollar corporation IDT. Serial entrepreneur with B.A. in Economics from Harvard University. Chairman of the Board of Directors of Rafael Holdings.
Alberto Gabizon, Co-founder of LipoMedix, renowned Professor of Medical Oncology at Shaare Zedek Medical Center and the Hebrew University of Jerusalem, expert in all aspects of liposome technology related to drug development, and co-inventor of Doxil®, a powerful and successful liposomal anticancer drug.
Sanjeev Luther, Expert in the pharmaceutical industry working in business development and operations, currently Chief Executive Officer of Rafael Pharmaceuticals., a company operating under Rafael Holdings 
Miranda J. Toledano, serves as Chief Operating Officer and Chief Financial Officer at TRIGR Therapeutics. From September 2016 until August 2017, served on the executive management team of Sorrento Therapeutics as EVP Corporate Development. From 2012 to 2016, served as Head of Healthcare Investment Banking at MLV & Co. Prior to joining MLV, from 2004 until 2010, she served in the investment group of Royalty Pharma, a leading investment firm with over $15 billion in biotherapeutic royalty assets. Ms. Toledano holds a BA in Economics from Tufts University and an MBA in Finance and Entrepreneurship from the NYU Stern School of Business.
Jacob Serfati Representing Kepler Holdings, expert investor, in the Latin-American pharmaceutical industry and founder of Jayor Pharmaceutical Co., from Miami, FL. 
Rami Kremien, Co-founder of Lipomedix, business investor with 35 years of experience in banking industry and in finance & business management.
Dov Schwell, Founder and Managing Partner of SWA and heads the firm’s Corporate, M&A and Securities practices. 25 years of experience in corporate, transactional and securities matters, including public and private offerings of equity and debt securities, mergers and acquisitions of public and private entities, private equity, investment and exits, joint ventures, workouts, and general commercial and corporate representation